SABSW
USDSAB Biotherapeutics Inc. Warrant
Echtzeitkurs
Kursdiagramm
Schlüsselkennzahlen
Marktkennzahlen
Eröffnung
$0.048
Hoch
$0.039
Tief
$0.028
Volumen
0.01M
Unternehmensfundamentaldaten
Branche
Biotechnologie
Land
United States
Handelsstatistiken
Börse
NCM
Währung
USD
52-Wochen-Spanne
Ähnliche Nachrichten
SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (NASDAQ:SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other
SAB BIO to Participate in Upcoming Investor Conferences
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for autoimmune diseases, including its
Ähnliche Aktien
MTDR
Matador Resources Company
VGI
Virtus Global Multi-Sector Income Fund Common Shares of Beneficial Interest
MIST
Milestone Pharmaceuticals Inc. Common Shares
HTLFP
Heartland Financial USA Inc. Depositary Shares each representing a 1/400th ownership interest in a share of 7.00% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series E
EFSCP
Enterprise Financial Services Corporation Depositary Shares Each Representing a 1/40th Interest in a Share of 5% Fixed Rate Non-Cumulative Perpetual Preferred Stock Series A
Bleiben Sie auf dem Laufenden
Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.